Telangana Drugs Control Administration Seizes Antibiotics Worth ₹1.33 Crore in Major Crackdown
Siddipet, November 27, 2024: The Telangana Drugs Control Administration (DCA) has seized a massive stock of antibiotics worth ₹1.33 crore from the manufacturing facility of Jodas Expoim Pvt. Ltd., located in Biotech Park, Karakapatla, Siddipet district. The raid uncovered violations involving false labeling, unauthorized packing, and fraudulent export practices.
Details of the Seizure
On November 26, 2024, acting on credible information, DCA officials raided the facility at Plot No. 55, Phase-III, Biotech Park. During the inspection, officials found significant stocks of antibiotics in the Finished Goods Warehouse that were in violation of the provisions of the Drugs and Cosmetics Act, 1940.
The investigation revealed that Ampicillin + Sulbactam 1000 mg + 500 mg injections (Batch No. JD4479), comprising 38,175 vials, were falsely labeled as manufactured by Jodas Expoim Pvt. Ltd., India, and Alpa Laboratories Ltd., Indore. However, the batch was actually produced by Indian Genomix Pvt. Ltd., located in Cherlapally, Medchal-Malkajgiri district.
This batch was being exported to Russia under false claims that it was manufactured by Jodas Expoim Pvt. Ltd.
Unauthorized Exports Detected
Further investigations revealed that other antibiotic stocks, including:
Amoxicillin 1000 mg + Clavulanic Acid 200 mg
Ampicillin + Sulbactam 2000 mg + 1000 mg
Meropenem 500 mg
…had been fraudulently exported to Russia in October and November 2024. These antibiotics, manufactured by other pharmaceutical companies, were falsely packed and labeled under the name of Jodas Expoim Pvt. Ltd.
Violations Found
The DCA found that Jodas Expoim Pvt. Ltd. had engaged in unauthorized packing of antibiotics and misrepresentation of manufacturing details to facilitate exports.
The Drugs Control Administration has initiated legal proceedings against the company under the Drugs and Cosmetics Act, 1940, to ensure accountability and prevent further violations.
This operation underscores the Telangana Government’s commitment to maintaining strict regulatory oversight in the pharmaceutical sector and ensuring compliance with legal and ethical standards.
